Related Articles
IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion
Gene silencing of indoleamine 2,3-dioxygenase hinders tumor growth through angiogenesis inhibition
Targeting the STAT5A/IDO1 axis overcomes radioresistance and reverses the immunosuppressive tumor microenvironment in NSCLC
High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer
Prognostic implications of immune classification using IDO1 expression in extrahepatic bile duct carcinoma